In this study, the authors compared the ER + MCF7 with the TNBC MDA-MB-231 cell line to look for ER + BC-specific sgRNAs, finding that one CBE had a role in PREX1 activation, which is associated with favourable outcomes following endocrine therapy. The gene discussed is ESR1; the disease is breast cancer.